Folfirinox: all 53 studies that test it

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma.Not yet recruitingNCT07808567Phase 2
• Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07733050Phase 2
• Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver MetastasisRecruitingNCT07193862Early Phase 1
• Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)RecruitingNCT05733689Phase 1
• NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)RecruitingNCT05529940Phase 3
• Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerRecruitingNCT05462496Phase 2
• Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic CancerRecruitingNCT05132504Phase 2
• mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer PatientsRecruitingNCT04084496Phase 2
• Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric CancerRecruitingNCT03825861Phase 2
• Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic AdenocarcinomaRecruitingNCT03484299Phase 1
• Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal AdenocarcinomaCompletedNCT04292743Phase 1Results posted
• Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal CancerCompletedNCT03828799Phase 1/2Results posted
• Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or GemcitabineTerminatedNCT03714555Phase 2Results posted
• FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasTerminatedNCT03042780Phase 2Results posted
• First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus FirgemCompletedNCT02352337Phase 2Results posted
• Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic CancerTerminatedNCT02243007Phase 2Results posted
• A Phase II Study of Neoadjuvant FOLFIRINOXCompletedNCT02178709Phase 2Results posted
• Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic CancerCompletedNCT02128100Phase 2Results posted
• FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic CancerCompletedNCT01896869Phase 2Results posted
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaCompletedNCT01839799Phase 2Results posted
• Radiation w/FOLFIRINOX-Losartan for Pancreatic CancerCompletedNCT01821729Phase 2Results posted
• Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")CompletedNCT01726582Phase 2Results posted
• FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerTerminatedNCT01688336Phase 2Results posted
• A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in PatientsCompletedNCT01661088Phase 2Results posted
• FOLFIRINOX + RT for Pancreatic CancerCompletedNCT01591733Phase 2Results posted
• Study of Modified FOLFIRINOX in Advanced Pancreatic CancerCompletedNCT01523457Phase 2Results posted
• Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood TestActive, not recruitingNCT07340567Phase 3
• Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal CancerActive, not recruitingNCT05868317Phase 2
• Redefining FOLFIORINOX in Older Pancreatic Cancer PatientsActive, not recruitingNCT05360732Phase 2
• Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic CancerStatus unknownNCT05262452Not applicable
• Brazilian Total Neoadjuvant Therapy TrialStatus unknownNCT05081687Phase 3
• A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT04990037Phase 1
• Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic CancerStatus unknownNCT04897854Phase 3
• A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus CancerStatus unknownNCT04611724Phase 2
• Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic AdenocarcinomaActive, not recruitingNCT04594772Phase 2
• Pancreatic Adenocarcinoma Signature Stratification for TreatmentCompletedNCT04469556Phase 2
• ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic StudyCompletedNCT04431258Phase 1/2
• Systemic Chemotherapy Plus PD-1 for Metastasis ICCWithdrawnNCT04398927Phase 2
• Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic CarcinomaWithdrawnNCT04270929Phase 1
• Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic CancerWithdrawnNCT04130399Phase 2
• HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCCStatus unknownNCT03812783Phase 2
• Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerTerminatedNCT03600623Early Phase 1
• Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract CancersTerminatedNCT03291899Phase 2
• Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot StudyTerminatedNCT02782182Phase 1
• Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerStatus unknownNCT02717091Phase 2
• Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic AdenocarcinomaWithdrawnNCT02592395Phase 1
• Second Line Chemotherapy FOLFIRINOX in Irresectable CholangiocarcinomaCompletedNCT02456714Phase 2
• First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.CompletedNCT01964287Phase 1/2
• Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease CancerStatus unknownNCT01771146Not applicable
• A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT01676259Phase 2
• Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerCompletedNCT01488552Phase 1/2
• FOLFIRINOX Plus IPI-926 for Advanced Pancreatic AdenocarcinomaCompletedNCT01383538Phase 1
• Intensified Chemotherapy in CRC After Resection of Liver MetastasesCompletedNCT00208260Phase 2/3

← Folfirinox overview